Net sales fell 43.6% year-over-year to SEK 7.3 million in H1 2024, with a net loss of SEK -6.2 million. A rights issue raised SEK 14.5 million, and a SEK 2.6 million volume order was secured from Pathogen Systems Inc.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.